Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging

NCT03568448 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

HER2 Negative Breast Cancer

Interventions

OTHER: Response monitoring (no intervention)

Sponsor

New Mexico Cancer Research Alliance